Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBraemar Shipping Regulatory News (BMS)

Share Price Information for Braemar Shipping (BMS)

Share Price is delayed by 15 minutes
Get Live Data
242.00    0.00 (0.00%)
Bid:
229.00
Ask:
241.00
Spread: 12.00 (5.24%)
Market Cap: £77.41m
BMS Live PriceLast checked at - London Stock Exchange

Intraday Braemar Shipping Share Chart

Director/PDMR Shareholding

23 May 2024 14:42

RNS Number : 7118P
Braemar PLC
23 May 2024
 

 

23 May 2024

BRAEMAR PLC

("Braemar" the "Company")

Director/PDMR Shareholding

 

Braemar Plc (LSE: BMS), a leading provider of expert investment, chartering and risk management advice to the shipping and energy markets, announces that James Gundy, Group Chief Executive Officer, purchased 6,600 ordinary shares of 10 pence each in the capital of the Company on 23 May 2024. Following this transaction, James Gundy's total shareholding is now 778,765.

The notification set out below is provided in accordance with the requirements of the EU Market Abuse Regulation, which is part of UK law by virtue of the European Union (Withdrawal) Act 2018.

 

 

For further information, contact:

 

Braemar Plc

James Gundy, Group Chief Executive Officer

Tel +44 (0) 20 3142 4100

Grant Foley, Group Chief Financial Officer

 

Rebecca-Joy Wekwete, Company Secretary

 

Buchanan

Charles Ryland / Stephanie Whitmore

Jack Devoy / Abby Gilchrist

Tel +44 (0) 20 7466 5000

Investec Bank plc

Gary Clarence / Alice King

 

 

Tel +44 (0) 20 7597 5970

Cavendish Securities PLC

Ben Jeynes / Matt Lewis (Corporate Finance)

Leif Powis / Dale Bellis / Charlie Combe (Sales & ECM)

 

 

Tel +44 (0) 20 7220 0500

 

 

Details of the person discharging managerial responsibilities / person closely associated

 

Name

James Gundy

 

Reason for the notification

Position/status

 

Group Chief Executive Officer

 

Initial notification /Amendment

Initial

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 

 

Name

Braemar Plc

 

LEI

213800EV6IKTTHJ83C19

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted 

 

Description of the financial instrument, type of instrument

 

Ordinary shares of 10p each 

Identification code

 

GB0000600931

Nature of the transaction 

 

Purchase of ordinary shares of 10p each.

Price(s) and volume(s)

Price: £2.905

 

Volume: 6,600

Aggregated information

 - Price

- Aggregated volume

 

Price: £19,173.00

Volume: 6,600

Date of the transaction

23 May 2024

 

Place of the transaction 

London Stock Exchange

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHDZGZKFFGGDZM
Date   Source Headline
31st Jul 20231:32 pmRNSTotal Voting Rights
17th Jul 20233:41 pmRNSAGM Statement
5th Jul 20235:40 pmRNSHolding(s) in Company
3rd Jul 20239:33 amRNSTemporary Suspension
3rd Jul 20237:30 amRNSSuspension - Braemar Plc
30th Jun 20237:00 amRNSTotal Voting Rights
26th Jun 20237:00 amRNSUpdate on trading, FY23 results & investigation
20th Jun 20237:00 amRNSDirectorate Change
2nd Jun 202310:44 amRNSCapital Reduction – Court approval
31st May 202311:56 amRNSTotal Voting Rights
23rd May 20234:31 pmRNSUpdate on publishing accounts
17th May 20237:00 amRNSAnnouncement of Board Appointment
16th May 202311:07 amRNSHolding(s) in Company
28th Apr 20237:00 amRNSTotal Voting Rights
18th Apr 202312:05 pmRNSResults of General Meeting
31st Mar 20238:33 amRNSTotal Voting Rights
29th Mar 202311:40 amRNSPublication of Circular & General Meeting Notice
22nd Mar 20237:00 amRNSTrading update - a record year for Braemar
28th Feb 20232:54 pmRNSTotal Voting Rights
27th Feb 20239:20 amRNSDirector/PDMR Shareholding
16th Feb 20234:16 pmRNSGrant of Share Incentives to PDMRs
14th Feb 20237:00 amRNSTrading Update and Proposed Capital Reduction
10th Feb 20231:50 pmRNSBlock listing Interim Review
1st Feb 20232:30 pmRNSTotal Voting Rights
1st Feb 20231:00 pmRNSIssue of Shares
4th Jan 20237:00 amRNSBoard change
30th Dec 20227:00 amRNSTotal Voting Rights
22nd Dec 202212:45 pmRNSDirector/PDMR Shareholding
22nd Dec 20227:00 amRNSIssue of Shares / PDMR Shareholding
19th Dec 20227:00 amRNSBraemar Acquires Leading US Shipbroker
12th Dec 20227:00 amRNSBraemar Launches Greek Corporate Finance Desk
6th Dec 20227:00 amRNSBraemar-New Tanker Desk and Opens Spanish Office
30th Nov 20224:38 pmRNSTotal Voting Rights
24th Nov 20227:00 amRNSInvestor Presentation
15th Nov 20227:00 amRNSInterim Results
14th Nov 202210:59 amRNSNotice of Half Year Results
3rd Nov 20222:01 pmRNSBraemar Continues to Build its Securities Offering
31st Oct 20227:00 amRNSTotal Voting Rights
6th Oct 20222:04 pmRNSResults of Annual General Meeting
30th Sep 20227:00 amRNSTotal Voting Rights
29th Sep 20227:00 amRNSPre-close trading update
14th Sep 20223:58 pmRNSPublication of Annual Report
14th Sep 20222:00 pmRNSChange of Name
13th Sep 20226:01 pmRNSHolding(s) in Company
13th Sep 20224:01 pmRNSDirector/PDMR Shareholding – Correction
8th Sep 20227:45 amRNSDirector/PDMR Shareholding
5th Sep 20222:45 pmRNSDirector/PDMR Shareholding
31st Aug 20224:33 pmRNSTotal Voting Rights
31st Aug 20221:18 pmRNSAnnual Report & Notice of General Meeting
30th Aug 202210:13 amRNSInvestor Presentation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.